Improving heart failure care for Medicare patients
Official title: Evaluating Policies to Improve Heart Failure Outcomes in Medicare
Funded at Beth Israel Deaconess Medical Center · NIH-10865455 · Data updated 2026-11-12
This study looks at how new Medicare policies can improve care for the 6.5 million Americans with heart failure, especially those on Medicare, by comparing their experiences with different Medicare plans and seeing how recent changes might help lower their medication costs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $169,416 |
| NIH project number | 1K23HL173636-01 |
| Project ID | NIH-10865455 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Medicare beneficiaries diagnosed with heart failure.
✕Less likely to help
Patients who are not enrolled in Medicare or do not have a diagnosis of heart failure may not benefit from this research.
What this research studies
This research investigates how recent Medicare policy changes can enhance care for the 6.5 million Americans with heart failure, particularly those enrolled in Medicare. It compares the experiences of patients in Medicare Advantage plans versus traditional fee-for-service Medicare, focusing on access to care, affordability, and health outcomes. The study also examines the impact of the Inflation Reduction Act, which aims to lower out-of-pocket drug costs for Medicare beneficiaries. By analyzing these factors, the research seeks to identify effective strategies to improve heart failure management.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and better access to care for heart failure patients on Medicare.
How similar studies have gone: Previous research has shown that policy changes can significantly impact healthcare access and outcomes, suggesting potential success for this approach.
Where this research is happening
-
Beth Israel Deaconess Medical Center
Boston, United States Active
Researchers
- Principal investigator: Oseran, Andrew Seymour — Beth Israel Deaconess Medical Center
- Study coordinator: Oseran, Andrew Seymour
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Digital-first heart failure care delivery in Uganda
A targeted program in Uganda tests a digital care plan to help people with heart failure manage their symptoms at home.
-
Digital-first heart failure care delivery in Uganda
A study to test digital self-care tools to help people with heart failure in Uganda manage symptoms and stay healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.